Skip to main content
. 2022 Mar 30;2022:9567041. doi: 10.1155/2022/9567041

Table 1.

Neoadjuvant treatment to decrease microvascular invasion.

Author Years Study types No. of study No. of patients Therapy The rate of MVI (%) OR 95% CI
Wang et al. 2020 Meta-analysis 6 4988 Antiviral therapy vs. surgery directly / 0.6 0.49-0.73
Yang et al. 2021 Propensity score matching retrospective study 1 1624 Preoperative TACE vs. surgery directly 38.85% vs. 41.10%,P = 0.473 / /